← All organizations

Pulmatrix Inc.

For profitWebsite ↗

Also known as: Pulmatrix Inc.

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 2

First clinical trial

Last known activity

Dec 31, 2022

Timeline

2000s

Jan 1, 2003
Pulmatrix Inc.— Founded

Drugs by trial phase (11 distinct, 14 trials)

Phase 2 (3 own, 0 via acquisition)

Phase 1 (8 own, 0 via acquisition)

Indications

Studied for

Recent trials (20)

NCT05667662Lead sponsorPhase 2Dec 31, 2022
NCT05667662Study directorPhase 2Dec 31, 2022
NCT05351086Lead sponsorPhase 1Jun 9, 2022
NCT04759807Lead sponsorPhase 1Jan 4, 2021
NCT03960606Lead sponsorPhase 2Jun 30, 2019
NCT03479411Study directorPhase 1Feb 9, 2018
NCT03479411Lead sponsorPhase 1Feb 9, 2018
NCT02671825Study directorPhase 1Jan 1, 2016
NCT02671825Lead sponsorPhase 1Jan 1, 2016
NCT02280395Lead sponsorPhase 1/Phase 2Oct 1, 2014
NCT02198963Lead sponsorPhase 1Jul 1, 2014
NCT01921712Lead sponsorPhase 1Jul 1, 2013
NCT01921712Study directorPhase 1Jul 1, 2013
NCT01690949Lead sponsorPhase 1Aug 1, 2012
NCT01690949Study directorPhase 1Aug 1, 2012

Details

Founded: Lexington, MA, US Jan 1, 2003
Last known activity: Dec 31, 2022